Healthequity (HQY) Debt to Equity (2012 - 2026)
Healthequity (HQY) debt to equity from Jan 31, 2012 to Apr 30, 2026. The current Healthequity (HQY) debt to equity is 46.04%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Debt to Equity
Debt to Equity
Annual Debt to Equity change of Healthequity (HQY)
| Year | Debt to Equity | Change |
|---|---|---|
| 2026 | 45.43% | -9.03% |
| 2025 | 49.95% | +16.16% |
| 2024 | 43.00% | -11.92% |
| 2023 | 48.81% | -2.85% |
| 2022 | 50.25% | -29.79% |
| 2021 | 71.57% | -39.59% |
| 2020 | 118.48% | N/A |
| 2019 | 0.00% | N/A |
| 2018 | 0.00% | N/A |
| 2017 | 0.00% | N/A |
| 2016 | 0.00% | N/A |
| 2015 | 0.00% | N/A |
| 2014 | 0.00% | N/A |
| 2013 | 0.00% | N/A |
| 2012 | 0.00% | N/A |
Comparison Healthequity (HQY) debt to equity with competitors
Healthequity (HQY) debt to equity is 46.04%.
| Ticker | Name | Debt to Equity | Upside |
|---|---|---|---|
| ZCMD | Zhongchao Inc - Class A | 0.14% | -99.70% |
| PHR | Phreesia Inc | 0.17% | -99.63% |
| MNDR | Mobile health Network Solutions - Class A | 1.48% | -96.79% |
| SY | So-Young International Inc | 2.56% | -94.43% |
| HCTI | Healthcare Triangle Inc | 16.07% | -65.10% |
| CARL | Carlsmed Inc | 16.66% | -63.83% |
| OPRX | OptimizeRx Corp | 18.01% | -60.88% |
| PINC | Premier Inc - Class A | 18.32% | -60.21% |
| VSEE | VSee Health Inc | 20.66% | -55.14% |
| CERT | Certara Inc | 28.76% | -37.54% |
| WAY | Waystar Holding Corp | 37.33% | -18.93% |
| DRIO | DarioHealth Corp | 49.58% | +7.70% |
| GDRX | GoodRx Holdings Inc - Class A | 78.37% | +70.20% |
| RCM | R1 RCM Inc | 78.60% | +70.71% |
| DH | Definitive Healthcare Corp - Class A | 85.34% | +85.34% |
| TBRG | TruBridge Inc | 91.70% | +99.16% |
| HCAT | Health Catalyst Inc | 111.02% | +141.12% |
| BTSG | BrightSpring Health Services Inc | 126.20% | +174.09% |
| BTSGU | BrightSpring Health Services Inc | 126.20% | +174.09% |
| SOPH | SOPHiA Genetics SA | 136.63% | +196.76% |
| EVH | Evolent Health Inc - Class A | 245.59% | +433.40% |
| TEM | Tempus AI Inc - Class A | 316.65% | +587.74% |
| NRC | National Research Corp | 548.48% | +1091.26% |